---
figid: PMC9146299__pharmaceutics-14-01001-g031
figtitle: Comprehensive Overview of Globally Approved JAK Inhibitors
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
pmcid: PMC9146299
filename: pharmaceutics-14-01001-g031.jpg
figlink: /pmc/articles/PMC9146299/figure/pharmaceutics-14-01001-f031/
number: F31
caption: Proposed metabolic pathway and metabolites of fedratinib in humans.
papertitle: A Comprehensive Overview of Globally Approved JAK Inhibitors.
reftext: Ahmed M. Shawky, et al. Pharmaceutics. 2022 May;14(5):1001.
year: '2022'
doi: 10.3390/pharmaceutics14051001
journal_title: Pharmaceutics
journal_nlm_ta: Pharmaceutics
publisher_name: MDPI
keywords: JAK | synthesis | kinase inhibitory activity | pharmacological uses | binding
  mode/interactions
automl_pathway: 0.932802
figid_alias: PMC9146299__F31
figtype: Figure
redirect_from: /figures/PMC9146299__F31
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9146299__pharmaceutics-14-01001-g031.html
  '@type': Dataset
  description: Proposed metabolic pathway and metabolites of fedratinib in humans.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Hn
  - Pa
  - l(1)MZ16
  - l(1)MZ17
  - gro
  - l(1)MZ10
  - l(3)87Dd
  - l(1)MZ14
---
